BU-NOT-SET

CONTACT US
Regulatory requirements for drug substances
  • Drug substance
Product check
Insight
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Poster
  • Drug substance
Innovative ALS Tablet Development
Insight
  • Drug product
  • Manufacturing
How Blow-fill-seal (BFS) technology may be a superior alternative to glass vials during the early stages of a development project
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products